| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A fludarabine and melphalan reduced-intensity conditioning regimen for HSCT in fifteen chronic granulomatous disease patients and a literature review
|
Vaezi, Mohammad
|
|
|
101 |
4 |
p. 869-880
|
artikel
|
| 2 |
A novel SPTB mutation causes hereditary spherocytosis via loss-of-function of β-spectrin
|
Li, Shan
|
|
|
101 |
4 |
p. 731-738
|
artikel
|
| 3 |
A rare de novo pure erythroid leukemia with JAK2 R683S mutation
|
Xu, Rebecca Z
|
|
|
101 |
4 |
p. 921-922
|
artikel
|
| 4 |
Association of blood type A with increased risk of severe COVID-19 in healthcare workers
|
Mahajan, Niraj N.
|
|
|
101 |
4 |
p. 933-934
|
artikel
|
| 5 |
Benefit of high-dose idarubicin as induction therapy in acute myeloid leukemia: a prospective phase 2 study
|
Mao, Yue-ying
|
|
|
101 |
4 |
p. 831-836
|
artikel
|
| 6 |
3′CBFB deletion in CBFB-rearranged acute myeloid leukemia retains morphological features associated with inv(16), but patients have higher risk of relapse and may require stem cell transplant
|
Tang, Guilin
|
|
|
101 |
4 |
p. 847-854
|
artikel
|
| 7 |
CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression—a potential differential diagnostic pitfall between PTLD and PTSMT
|
Suhren, Jan-Theile
|
|
|
101 |
4 |
p. 881-883
|
artikel
|
| 8 |
Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL)
|
Janikova, A.
|
|
|
101 |
4 |
p. 789-798
|
artikel
|
| 9 |
Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations
|
Dutta, Sayantanee
|
|
|
101 |
4 |
p. 837-846
|
artikel
|
| 10 |
Coombs’ test positive autoimmune hemolytic anemia accompanied by myelodysplastic syndrome that became Coombs’ test negative after azacitidine administration
|
Yamada, Shinya
|
|
|
101 |
4 |
p. 915-917
|
artikel
|
| 11 |
Detection of pulse rate elevation by Apple Watch in a patient with bronchiolitis obliterans syndrome after allogeneic stem cell transplantation
|
Mushino, Toshiki
|
|
|
101 |
4 |
p. 897-899
|
artikel
|
| 12 |
Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosis
|
Luque Paz, Damien
|
|
|
101 |
4 |
p. 893-896
|
artikel
|
| 13 |
Efficacy and safety comparison between R-CHOP and modified NHL-BFM-90 regimens in children and adolescents with diffuse large B-cell lymphoma
|
Guan, Jinqiu
|
|
|
101 |
4 |
p. 763-771
|
artikel
|
| 14 |
Falsely elevated serum vitamin B12 levels in a case of pernicious anemia
|
Thong, Edwin W. S.
|
|
|
101 |
4 |
p. 889-892
|
artikel
|
| 15 |
Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study
|
Martella, Federica
|
|
|
101 |
4 |
p. 855-867
|
artikel
|
| 16 |
Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomy
|
Caocci, Giovanni
|
|
|
101 |
4 |
p. 749-754
|
artikel
|
| 17 |
HLA-G-ILT2 interaction contributes to suppression of bone marrow B cell proliferation in acquired aplastic anemia
|
Sun, Yuan-xin
|
|
|
101 |
4 |
p. 739-748
|
artikel
|
| 18 |
Identification of CD105 (endoglin) as novel risk marker in CLL
|
Greiner, Sarah M.
|
|
|
101 |
4 |
p. 773-780
|
artikel
|
| 19 |
Indolent T cell lymphoma involving the central nervous system and successfully treated by bendamustine
|
Hui, Min
|
|
|
101 |
4 |
p. 911-913
|
artikel
|
| 20 |
Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells
|
Mack, Elisabeth K. M.
|
|
|
101 |
4 |
p. 811-824
|
artikel
|
| 21 |
Mortality by COVID-19 in adults with acute myeloid leukemia: a survey with hematologists in Brazil
|
Fagundes, Evandro M.
|
|
|
101 |
4 |
p. 923-925
|
artikel
|
| 22 |
Need for integrating early palliative care with standard hematology care long before the allogeneic hemopoietic stem cells transplantation
|
Potenza, Leonardo
|
|
|
101 |
4 |
p. 905-906
|
artikel
|
| 23 |
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL—a matched cohort analysis
|
Avivi, Irit
|
|
|
101 |
4 |
p. 755-762
|
artikel
|
| 24 |
Previously unreported WRAP53 gene variants in a patient with dyskeratosis congenita
|
Brailovski, Eugene
|
|
|
101 |
4 |
p. 907-909
|
artikel
|
| 25 |
Prognostic implication of CTLA-4, PD-1, and PD-L1 expression in aggressive adult T-cell leukemia–lymphoma
|
Onishi, Akio
|
|
|
101 |
4 |
p. 799-810
|
artikel
|
| 26 |
Revisiting the impact of immunoglobulin isotypes in multiple myeloma
|
Bal, Susan
|
|
|
101 |
4 |
p. 825-829
|
artikel
|
| 27 |
Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis
|
Caocci, Giovanni
|
|
|
101 |
4 |
p. 929-931
|
artikel
|
| 28 |
T-cell receptor-silent peripheral T-cell lymphoma complicated with hemophagocytic lymphohystiocytosis
|
Ono, Koya
|
|
|
101 |
4 |
p. 901-903
|
artikel
|
| 29 |
The incidental discovery of a constitutional trisomy 21 mosaicism in an adult female with myelodysplastic/myeloproliferative neoplasm
|
O’Hagan Henderson, Samantha
|
|
|
101 |
4 |
p. 919-920
|
artikel
|
| 30 |
Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccination
|
Kemper, Marcel
|
|
|
101 |
4 |
p. 927-928
|
artikel
|
| 31 |
Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination
|
Saito, Kei
|
|
|
101 |
4 |
p. 885-887
|
artikel
|
| 32 |
90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years
|
Rieger, Kathrin
|
|
|
101 |
4 |
p. 781-788
|
artikel
|
Tijdschrift beschrijving